Table 6 Clinical and economic effects of the vaccination programme

 Avoided hospitalized pneumonias

1,134

5,755

13,078

21,471

29,998

71,436

 Avoided outpatient pneumonias

762

3,869

8,792

14,434

20,166

48,022

 Avoided primary bacteremias

31

156

313

572

686

1,758

 Avoided empyemas

0

2

4

8

9

24

 Avoided meningitis

10

51

103

189

226

579

 Avoided bacteremic pneumonias

71

363

728

1,330

1,594

4,087

Avoided contagions

2,008

10,196

23,018

38,004

52,680

125,906

 Hospitalized pneumonia cost savings

2,247,819

11,411,544

25,933,983

42,577,699

59,486,125

141,657,169

 Outpatient pneumonia cost savings

190,504

967,134

2,197,917

3,608,480

5,041,478

12,005,513

 Primary bacteremias cost savings

125,824

639,232

1,281,675

2,341,411

2,807,267

7,195,409

 Empyemas cost savings

2,486

12,628

25,319

46,254

55,457

142,145

 Meningitis cost savings

113,513

576,685

1,156,266

2,112,310

2,532,584

6,491,358

 Bacteremic pneumonias cost savings

387,336

1,967,803

3,945,487

7,207,762

8,641,848

22,150,236

Savings by all cases averted

3,067,481

15,575,025

34,540,648

57,893,917

78,564,759

189,641,830

 Cost of vaccinations

15,197,172

15,197,172

15,197,172

15,197,172

15,197,172

75,985,862

 Net healthcare cost

12,129,691

−377,853

−19,343,475

−42,696,744

−63,367,587

−113,655,968

Discounted net healthcare cost

12,129,691

−366,848

−18,233,081

−39,073,569

−56,301,280

−101,845,087